Global BioDiagnostics
Innovating accessible and swift diagnostic solutions for tuberculosis since 2009.
Innovating accessible and swift diagnostic solutions for tuberculosis since 2009.
Global BioDiagnostics is a biotechnology startup focused on revolutionizing tuberculosis diagnosis since 2009. Their slogan, "Innovating accessible and swift diagnostic solutions for tuberculosis since 2009," embodies their commitment to developing quick, affordable, and user-friendly Point-of-Care tests for active tuberculosis. The company is headquartered in Temple, Texas and operates within the Health Care industry. Notably, they secured a $1.25M Series A investment on 20 March 2015, with funding from Innovate Angel Funds and Turnstone Capital Management. This investment underscores the recognition and support from prominent venture capital firms for Global BioDiagnostics' groundbreaking approach to addressing crucial healthcare challenges.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $1.25M | 2 |
|
20 Mar 2015 |
| Venture Round | $1.97M | - | 03 Feb 2015 | |
| Equity Crowdfunding | Unknown | - | 31 May 2012 |
No recent news or press coverage available for Global BioDiagnostics.
We care about your data, and we'd love to use cookies make your experience better.